Health Kick Podcast: TrivarX hones the connection between sleep and depression
Health & Biotech
share
Stockhead columnist Tim Boreham is back in the studio for another instalment of Health Kick Podcast.
In this episode Tim chats with Kai Sun, Chief Operating Officer at TrivarX (ASX:TRI).
The medtech’s lead product, MEB-001 is an AI-driven screening and diagnostic tool which analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%.
It recently submitted a formal request to the US Food and Drug Administration for a pre-submission meeting to approve the design for a proposed pivotal trial.
Like to tune in through another app? Just search for Health Kick Podcast with Tim Boreham and subscribe!
This podcast was developed in collaboration with TrivarX, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
